Re: Pfizer enzalutimide perspective

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7656 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Pfizer enzalutimide perspective

in response to

Re: Pfizer enzalutimide perspective

BearDownAZ

posted on May 16, 2017 01:36PM

Thanks BDAZ, your comments are much appreciated.

tada

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply